BioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts

AbstractBackgroundTuberculosis (TB) is the second leading cause of death from a single infectious organism, demanding attention towards discovery of novel anti-tubercular compounds. Natural products or their derivatives have provided more than 50% of all existing drugs, offering a chemically diverse space for discovery of novel drugs.DescriptionBioPhytMol has been designed to systematically curate and analyze the anti-mycobacterial natural product chemical space. BioPhytMol is developed as a drug-discovery community resource with anti-mycobacterial phytomolecules and plant extracts. Currently, it holds 2582 entries including 188 plant families (692 genera and 808 species) from global flora, manually curated from literature. In total, there are 633 phytomolecules (with structures) curated against 25 target mycobacteria. Multiple analysis approaches have been used to prioritize the library for drug-like compounds, for both whole cell screening and target-based approaches. In order to represent the multidimensional data on chemical diversity, physiochemical properties and biological activity data of the compound library, novel approaches such as the use of circular graphs have been employed.ConclusionBioPhytMol has been designed to systematically represent and search for anti-mycobacterial phytochemical information. Extensive compound analyses can also be performed through web-application for prioritizing drug-like compounds. The resource is freely available online at http://ab-openlab.csir.res.in/biophytmol/. Graphical AbstractBioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts generated using Crowdsourcing. The platform comprises of manually curated data on antimycobacterial natural products along with tools to perform structure similarity and visualization. The platform allows for prioritization of drug like natural products for antimycobacterial drug discovery.

[1]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[2]  Wolfgang Sippl,et al.  AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants , 2013, PloS one.

[3]  S. Jachak,et al.  Challenges and opportunities in drug discovery from plants , 2007 .

[4]  Tudor I. Oprea,et al.  Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..

[5]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[6]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[7]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[8]  Joel S. Freundlich,et al.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. , 2011, Trends in Microbiology.

[9]  M. Lahlou,et al.  The Success of Natural Products in Drug Discovery , 2013 .

[10]  Mark S Butler,et al.  Natural products--the future scaffolds for novel antibiotics? , 2006, Biochemical pharmacology.

[11]  Alex M. Clark,et al.  New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0 , 2014, Journal of Cheminformatics.

[12]  Jun Feng,et al.  PowerMV: A Software Environment for Molecular Viewing, Descriptor Generation, Data Analysis and Hit Evaluation , 2005, J. Chem. Inf. Model..

[13]  Pratima Kumari,et al.  Nutraceuticals: A Boom to Medical Industry , 2013 .

[14]  G. Rishton.  Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.

[15]  Wolfgang Sippl,et al.  ConMedNP: a natural product library from Central African medicinal plants for drug discovery , 2014 .

[16]  Lirong Chen,et al.  Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology , 2013, PloS one.

[17]  Yi Sun,et al.  HIM-herbal ingredients in-vivo metabolism database , 2013, Journal of Cheminformatics.

[18]  Daniela Fernandes Ramos,et al.  New anti-tuberculosis drugs: strategies, sources and new molecules. , 2009, Current medicinal chemistry.

[19]  Pascal Amoa Onguéné,et al.  CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening , 2013, BMC Complementary and Alternative Medicine.

[20]  Gajendra P. S. Raghava,et al.  NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database , 2012, Nucleic Acids Res..

[21]  W. Folk,et al.  21st century natural product research and drug development and traditional medicines. , 2013, Natural product reports.

[22]  J. Bayona,et al.  Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis , 2010, The Lancet.

[23]  Alimuddin Zumla,et al.  Advances in the development of new tuberculosis drugs and treatment regimens , 2013, Nature Reviews Drug Discovery.

[24]  Mathias Dunkel,et al.  SuperNatural: a searchable database of available natural compounds , 2005, Nucleic Acids Res..

[25]  Virgilio Bocanegra-García,et al.  Recent advances in antitubercular natural products. , 2012, European journal of medicinal chemistry.

[26]  Adriano D Andricopulo,et al.  Development of a natural products database from the biodiversity of Brazil. , 2013, Journal of natural products.

[27]  Jon Cohen,et al.  Infectious disease. Approval of novel TB drug celebrated--with restraint. , 2013, Science.

[28]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[29]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[30]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[31]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[32]  Alfonso Mendoza,et al.  Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis , 2013, ChemMedChem.

[33]  Marc A. Martí-Renom,et al.  Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis , 2013, PLoS Comput. Biol..

[34]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[35]  Ferenc Csizmadia.  JChem: Java Applets and Modules Supporting Chemical Database Handling from Web Browsers , 2000, J. Chem. Inf. Comput. Sci..

[36]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[37]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.